Pliant Therapeutics (PLRX) Enterprise Value (2019 - 2026)
Pliant Therapeutics (PLRX) reported Enterprise Value of -$170.9 million for Q1 2026, up 44.09% year-over-year from -$118.6 million in Q1 2025, and up 10.5% quarter-over-quarter from -$190.9 million in Q4 2025.
Pliant Therapeutics (PLRX) Enterprise Value (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 8 years of Enterprise Value data on file, last reported at -$170.9 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$170.9 million, up 44.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$170.9 million (up 44.09% YoY), and the FY2025 annual result was -$190.9 million, up 46.32% from the prior year.
- Enterprise Value improved to -$170.9 million in Q1 2026 per PLRX's latest filing, from -$190.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$163.6 million in Q2 2022 and troughed at -$577.3 million in Q1 2023.
- A 5-year average of -$355.0 million and a median of -$355.7 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value tumbled 239.35% in 2023, then soared 46.32% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$331.2 million in 2022, then sank by 49.23% to -$494.2 million in 2023, then advanced by 28.03% to -$355.7 million in 2024, then soared by 46.32% to -$190.9 million in 2025, then grew by 10.5% to -$170.9 million in 2026.
- Business Quant data shows PLRX's Enterprise Value at -$170.9 million in Q1 2026, -$190.9 million in Q4 2025, and -$241.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | -170.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -170.89 Mn |
| Dec 31, 2025 | -190.94 Mn |
| Sep 30, 2025 | -241.80 Mn |
| Jun 30, 2025 | -262.87 Mn |
| Mar 31, 2025 | -305.65 Mn |
| Dec 31, 2024 | -355.72 Mn |
| Sep 30, 2024 | -404.51 Mn |
| Jun 30, 2024 | -436.61 Mn |
| Mar 31, 2024 | -482.39 Mn |
| Dec 31, 2023 | -494.25 Mn |
| Sep 30, 2023 | -523.61 Mn |
| Jun 30, 2023 | -555.16 Mn |
| Mar 31, 2023 | -577.31 Mn |
| Dec 31, 2022 | -331.19 Mn |
| Sep 30, 2022 | -360.24 Mn |
| Jun 30, 2022 | -163.60 Mn |
| Mar 31, 2022 | -178.28 Mn |
| Dec 31, 2021 | -200.60 Mn |
| Sep 30, 2021 | -221.04 Mn |
| Jun 30, 2021 | -243.98 Mn |